David B Seifer

Summary

Affiliation: Maimonides Medical Center
Country: USA

Publications

  1. ncbi request reprint Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles
    David B Seifer
    Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
    Fertil Steril 77:468-71. 2002
  2. ncbi request reprint Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance
    David B Seifer
    Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York 11228, USA
    Fertil Steril 88:539-46. 2007
  3. doi request reprint Strategic planning is long overdue and could mitigate long-term complications that result from delayed diagnosis of primary ovarian insufficiency
    David B Seifer
    Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, New York, USA
    Fertil Steril 95:1898; discussion 1902. 2011
  4. doi request reprint Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States
    David B Seifer
    Maimonides Medical Center, Department of Obstetrics and Gynecology, Genesis Fertility and Reproductive Medicine, Brooklyn, New York, USA
    Fertil Steril 95:747-50. 2011
  5. doi request reprint Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: Society for Assisted Reproductive Technology 1999 and 2000 vs. 2004-2006
    David B Seifer
    Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, 1355 84th Street, Brooklyn, NY 11228, USA
    Fertil Steril 93:626-35. 2010
  6. pmc Variations in serum müllerian inhibiting substance between white, black, and Hispanic women
    David B Seifer
    Department of Obstetrics and Gynecology, Brooklyn, and Mount Sinai School of Medicine, Maimonides Medical Center, New York, New York 11228, USA
    Fertil Steril 92:1674-8. 2009
  7. ncbi request reprint Disparity in assisted reproductive technologies outcomes in black women compared with white women
    David B Seifer
    Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, New York 11228, USA
    Fertil Steril 90:1701-10. 2008
  8. pmc Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women
    David B Seifer
    Maimonides Medical Center, Department of Obstetrics and Gynecology, Brooklyn, New York, USA
    Fertil Steril 88:1645-52. 2007
  9. doi request reprint Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation
    Reshef Tal
    Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, New York, USA
    Fertil Steril 100:538-43. 2013
  10. doi request reprint Plasma brain-derived neurotrophic factor in women after bariatric surgery: a pilot study
    Zaher O Merhi
    Maimonides Medical Center, Brooklyn, New York, USA
    Fertil Steril 91:1544-8. 2009

Research Grants

  1. BIOLOGICAL BASIS OF THE PERIMENOPAUSE
    DAVID SEIFER; Fiscal Year: 2002

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles
    David B Seifer
    Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
    Fertil Steril 77:468-71. 2002
    ....
  2. ncbi request reprint Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance
    David B Seifer
    Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York 11228, USA
    Fertil Steril 88:539-46. 2007
    ..To examine Mullerian Inhibiting Substance (MIS) as an emerging diagnostic marker of ovarian function...
  3. doi request reprint Strategic planning is long overdue and could mitigate long-term complications that result from delayed diagnosis of primary ovarian insufficiency
    David B Seifer
    Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, New York, USA
    Fertil Steril 95:1898; discussion 1902. 2011
    ..Timely diagnosis with less delay results in less morbidity and ultimately greater patient satisfaction with the quality of received medical care...
  4. doi request reprint Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States
    David B Seifer
    Maimonides Medical Center, Department of Obstetrics and Gynecology, Genesis Fertility and Reproductive Medicine, Brooklyn, New York, USA
    Fertil Steril 95:747-50. 2011
    ..To determine age-specific serum anti-Müllerian hormone (AMH) values for women presenting to U.S. fertility clinics...
  5. doi request reprint Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: Society for Assisted Reproductive Technology 1999 and 2000 vs. 2004-2006
    David B Seifer
    Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, 1355 84th Street, Brooklyn, NY 11228, USA
    Fertil Steril 93:626-35. 2010
    ..To determine trends in assisted reproductive technology (ART) in black and white women by comparing Society for Assisted Reproductive Technology (SART) database outcomes for 2004-2006 with previously reported outcomes for 1999 and 2000...
  6. pmc Variations in serum müllerian inhibiting substance between white, black, and Hispanic women
    David B Seifer
    Department of Obstetrics and Gynecology, Brooklyn, and Mount Sinai School of Medicine, Maimonides Medical Center, New York, New York 11228, USA
    Fertil Steril 92:1674-8. 2009
    ..To compare serum müllerian inhibiting substance (MIS) levels between white, black, and Hispanic women to determine whether ovarian aging occurs at a different time course for women of different racial groups...
  7. ncbi request reprint Disparity in assisted reproductive technologies outcomes in black women compared with white women
    David B Seifer
    Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, New York 11228, USA
    Fertil Steril 90:1701-10. 2008
    ..To compare success rates in black and white women undergoing IVF...
  8. pmc Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women
    David B Seifer
    Maimonides Medical Center, Department of Obstetrics and Gynecology, Brooklyn, New York, USA
    Fertil Steril 88:1645-52. 2007
    ..To determine whether HIV infection influences early follicular MIS levels, an early marker of ovarian aging...
  9. doi request reprint Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation
    Reshef Tal
    Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, New York, USA
    Fertil Steril 100:538-43. 2013
    ....
  10. doi request reprint Plasma brain-derived neurotrophic factor in women after bariatric surgery: a pilot study
    Zaher O Merhi
    Maimonides Medical Center, Brooklyn, New York, USA
    Fertil Steril 91:1544-8. 2009
    ..Brain-derived neurotrophic factor decreased significantly in all the participants and in the premenopausal group when looked at in isolation...
  11. ncbi request reprint Relationship of bariatric surgery to Müllerian-inhibiting substance levels
    Zaher O Merhi
    Maimonides Medical Center, 967 48th Street, Brooklyn, New York 11219, USA
    Fertil Steril 90:221-4. 2008
  12. ncbi request reprint Serum müllerian-inhibiting substance in Down's syndrome pregnancies
    David B Seifer
    Maimonides Medical Center, Brooklyn, New York, NY, USA
    Hum Reprod 22:1017-20. 2007
    ..To examine whether maternal serum levels of müllerian-inhibiting substance (MIS) differ in Down's syndrome and unaffected pregnancies...
  13. doi request reprint Follicular-fluid neurotrophin levels in women undergoing assisted reproductive technology for different etiologies of infertility
    Erkan Buyuk
    Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York, USA
    Fertil Steril 90:1611-5. 2008
    ..To determine follicular-fluid neurotrophin levels in women undergoing assisted reproductive techniques for different etiologies of infertility...
  14. doi request reprint Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles
    Reshef Tal
    Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, NY, USA
    Reprod Biomed Online 26:360-7. 2013
    ..In contrast, in women aged <34, AMH was not different between twin and singleton pregnancies. In conclusion, considering a woman's AMH before transferring more than one embryo may assist in reducing the incidence of twins...
  15. pmc Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women
    Muhammad Faisal Aslam
    Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York 11219, USA
    Fertil Steril 95:1790-3. 2011
    ..Unlike MIS, BDNF levels were not reduced after chemotherapy...
  16. pmc Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates
    Samantha F Butts
    Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Fertil Steril 99:382-8. 2013
    ....
  17. ncbi request reprint Comparison of serum and plasma measurements of Müllerian inhibiting substance
    Zaher O Merhi
    Maimonides Medical Center, Brooklyn, New York 11219, USA
    Fertil Steril 89:1836-7. 2008
    ..Levels of MIS were measured with an ELISA kit, and plasma levels were studied in parallel to serum samples. A 98.5% correlation was found between serum and plasma MIS values...
  18. ncbi request reprint Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol
    André Hazout
    ART Unit Eylau la Muette, Clinic La Muette, Paris, France
    Fertil Steril 82:1323-9. 2004
    ..To test the hypothesis that the concentration of early follicular phase serum antimullerian hormone (AMH) or mullerian-inhibiting substance (MIS) is a useful marker of ovarian response and assisted reproductive technology (ART) outcome...
  19. ncbi request reprint Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment
    Richard Fleming
    University Department of Obstetrics and Gynaecology, Royal Infirmary, Glasgow, United Kingdom
    Fertil Steril 83:130-6. 2005
    ..Assessment of ovarian responses to metformin treatment in obese women with polycystic ovary syndrome (PCOS)...
  20. ncbi request reprint Impact of retained embryos on the outcome of assisted reproductive technologies
    Hye Chun Lee
    Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, UMDNJ Robert Wood Johnson Medical School, 303 George Street, New Brunswick, NJ 08901, USA
    Fertil Steril 82:334-7. 2004
    ..To assess the impact of embryo retention in the embryo transfer catheter followed by "immediate" retransfer on pregnancy outcome in women undergoing assisted reproduction...
  21. ncbi request reprint Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women
    L Stewart Massad
    Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    J Womens Health (Larchmt) 15:591-8. 2006
    ..To describe menstrual abnormalities among women with HIV...
  22. ncbi request reprint Practice patterns among board-certified reproductive endocrinologists regarding high-order multiple gestations: a united states national survey
    Doreen L Hock
    Reproductive Medicine Associates of New Jersey, Somerset, USA
    Obstet Gynecol 99:763-70. 2002
    ..To assess current practice management, attitudes, and strategies of reproductive endocrinologists in the United States regarding high-order (at least three) multiple gestations...
  23. ncbi request reprint Social concerns of women undergoing infertility treatment
    Peter S Finamore
    Department of Obstetrics, Gynecology and Reproductive Sciences, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
    Fertil Steril 88:817-21. 2007
    ..We hypothesize that, in certain women, disclosure may lower stress, and therefore increase success rate of in vitro fertilization...
  24. ncbi request reprint DNA microarray analysis of the expression profiles of luteinized granulosa cells as a function of ovarian reserve
    Khew Voon Chin
    The Cancer Institute of New Jersey, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
    Fertil Steril 77:1214-8. 2002
    ..To examine the expression profiles of luteinized granulosa cells isolated from women with normal or diminished ovarian reserve undergoing in vitro fertilization...
  25. ncbi request reprint Mitochondrial deletions in luteinized granulosa cells as a function of age in women undergoing in vitro fertilization
    David B Seifer
    Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
    Fertil Steril 78:1046-8. 2002
    ..To test the hypothesis that mitochondrial DNA (mtDNA) deletions are more prevalent in granulosa cells from women of advanced reproductive age than from younger women undergoing IVF...
  26. ncbi request reprint Ovarian brain-derived neurotrophic factor is present in follicular fluid from normally cycling women
    David B Seifer
    Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
    Fertil Steril 79:451-2. 2003
  27. ncbi request reprint Immunocytochemical evidence for the presence and location of the neurotrophin-Trk receptor family in adult human preovulatory ovarian follicles
    David B Seifer
    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ, USA
    Am J Obstet Gynecol 194:1129-34; discussion 1134-6. 2006
    ..This study was undertaken to evaluate the presence or absence of neurotrophins and their respective receptors within adult human preovulatory follicles...

Research Grants1

  1. BIOLOGICAL BASIS OF THE PERIMENOPAUSE
    DAVID SEIFER; Fiscal Year: 2002
    ....